384
Views
0
CrossRef citations to date
0
Altmetric
Erratum

Erratum

This article refers to:
Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson’s disease

Carta AR, Simuni T. Thiazolidinediones under preclinical and early clinical development for the treatment of Parkinson’s disease. Expert Opin Investig Drugs. 2015 Feb; 24(2):219-27. http://www.tandfonline.com/doi/abs/10.1517/13543784.2015.963195

When the above article was first published, Tanya Simuni’s affiliation was omitted. The correct affiliation details are provided below.

Anna R Carta & Tanya Simuni§

†University of Cagliari, Department of Biomedical Science, Cagliari, Italy

§Parkinson’s disease and Movement Disorders Center, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA

Taylor and Francis apologises for this error.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.